Publications by authors named "Eric McGary"

Claim this Profile
U
Utilization of extended-interval, fixed-dosing of durvalumab, every 4 weeks, in U.S. patients with unresectable stage III NSCLC following concurrent chemoradiation.
Reina Haque, Eric McGary, Mike Z Yang, Raymond Liu, J Marie Suga

Future Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pharmacist managed oral epidermal growth factor receptor inhibitors.
Shirley Ng, Nicholas Baker, Fang Niu, Jed A Katzel, Hanh T Bergere, Eric McGary

J Oncol Pharm Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Half of oncologists fail to use ordered NGS results to guide their first-line treatment decision in advanced NSCLC: A retrospective study in a community-based integrated healthcare system.
Ahmed I Megahed, Dominick Zheng, Lie Hong Chen, Reina Haque, Eric C McGary

Heliyon· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial).
Michael J Morris, Glenn Heller, David W Hillman, Olivia Bobek, Charles Ryan, Eric C McGary

J Clin Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SWOG S1400C (NCT02154490)-A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy).
Martin J Edelman, Mary W Redman, Kathy S Albain, Eric C McGary, Noman M Rafique

J Thorac Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: Inhibition of Platelet-derived Growth Factor-mediated Proliferation of Osteosarcoma Cells by the Novel Tyrosine Kinase Inhibitor STI571.
Eric C McGary, Kristy Weber, Lisa Mills, Michelle Doucet, Valerie Lewis

Clin Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Amy B Heimberger, Eric C McGary, Dima Suki, Maribelis Ruiz, Huamin Wang

Clin Cancer Res· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of action of rapamycin in gliomas.
Amy B Heimberger, Enze Wang, Eric C McGary, Kenneth R Hess, Verlene K Henry

Neuro Oncol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo.
Dina Chelouche Lev, Amir Onn, Vladislava O Melinkova, Claudia Miller, Valerie Stone, Eric C McGary

J Clin Oncol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.
Eric C McGary, Amir Onn, Lisa Mills, Amy Heimberger, Omar Eton

J Invest Dermatol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
Eric C McGary, Amy Heimberger, Lisa Mills, Kristy Weber, Gary W Thomas

Clin Cancer Res· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular adhesion pathways and metastatic potential of human melanoma.
Eric C McGary, Dina Chelouche Lev, Menashe Bar-Eli

Cancer Biol Ther· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy.
Dina Chelouche Lev, Maribelis Ruiz, Lisa Mills, Eric C McGary, Janet E Price

Mol Cancer Ther· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571.
Eric C McGary, Kristy Weber, Lisa Mills, Michelle Doucet, Valerie Lewis

Clin Cancer Res· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis